comparemela.com

Latest Breaking News On - Hemaflo therapeutics - Page 1 : comparemela.com

Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave

ENGLEWOOD, CO, November 22, 2021 – Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammatory conditions, today announced that Mike Macaluso is taking a one-year medical leave of absence from his role as Chairman and CEO, effective immediat

United statesRoanoke collegeHolli cherevkaMike macalusoMichael martinoAmpio pharmaceuticalsAmpio pharmaceuticals incInterim chairmanAmpio boardHemaflo therapeuticsAcute kidney injuryCaravan biologixBiologics price competitionInnovation actFood and drug administrationForward looking statement

Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave

/PRNewswire/ Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent.

United statesRoanoke collegeHolli cherevkaMike macalusoMichael martinoDaniel stokelyExchange commissionAmpio pharmaceuticalsAmpio pharmaceuticals incInterim chairmanAmpio boardHemaflo therapeuticsAcute kidney injuryCaravan biologixBiologics price competitionInnovation act

Ampio Pharmaceuticals Strengthens Management Team and Board of Directors

/PRNewswire/ Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent.

United statesSouth africaRoanoke collegeCity ofUnited kingdomMichael martinoHoward levyMichaela martinoKevin buchiKatie kennedyMike macalusoHolli cherevkaJ kevin buchiAmerican college of radiologySonus pharmaceuticalsClinical research

vimarsana © 2020. All Rights Reserved.